Gries JM - Search Results

1

Incidence of adverse reactions to cyclosporine after liver transplantation is predicted by the first blood level.

Azoulay D, Lemoine A, Dennison A, Gries JM, Dolizy I, Castaing D, Beaune P, Bismuth H. Azoulay D, et al. Among authors: gries jm. Hepatology. 1993 Jun;17(6):1123-6. Hepatology. 1993. PMID: 8514263

2

[Relationship between hepatic cytochrome P-450 3A and acute cyclosporine toxicity in liver transplantation].

Lemoine A, Azoulay D, Kiffel L, Gries JM, Bismuth H, Debuire B, Beaune P. Lemoine A, et al. Among authors: gries jm. Therapie. 1994 May-Jun;49(3):279-82. Therapie. 1994. PMID: 7878595 French.

3

Lidocaine metabolite formation in the liver donor as a predictive test for the safe and efficient introduction of cyclosporine in the recipient.

Azoulay D, Lemoine A, Gries JM, Adam R, Dolizy I, Fredj G, Beaune P, Bismuth H. Azoulay D, et al. Among authors: gries jm. Transplant Proc. 1993 Jun;25(3):2275-8. Transplant Proc. 1993. PMID: 8516899 No abstract available.

4

Relationship between graft cytochrome P-450 3A content and early morbidity after liver transplantation.

Lemoine A, Azoulay D, Gries JM, Dennison A, Castaing D, Fredj G, Debuire B, Guengerich FP, Beaune P, Bismuth H. Lemoine A, et al. Among authors: gries jm. Transplantation. 1993 Dec;56(6):1410-4. doi: 10.1097/00007890-199312000-00026. Transplantation. 1993. PMID: 8279011

5

Relationship between cytochrome P-450 3A content of orthotopically transplanted liver and postoperative morbidity.

Azoulay D, Lemoine A, Dennison A, Gries JM, Dolizy I, Barbazza F, Bonhomme L, Beaune P, Bismuth H. Azoulay D, et al. Among authors: gries jm. Transplant Proc. 1993 Aug;25(4):2630-1. Transplant Proc. 1993. PMID: 8356702 No abstract available.

6

Cimetidine does not alter sparfloxacin pharmacokinetics.

Gries JM, Honorato J, Taburet AM, Alvarez MP, Sadaba B, Azanza JR, Singlas E. Gries JM, et al. Int J Clin Pharmacol Ther. 1995 Nov;33(11):585-7. Int J Clin Pharmacol Ther. 1995. PMID: 8688981 Clinical Trial.

7

Peginterferon alfa-2a does not alter the pharmacokinetics of methadone in patients with chronic hepatitis C undergoing methadone maintenance therapy.

Sulkowski M, Wright T, Rossi S, Arora S, Lamb M, Wang K, Gries JM, Yalamanchili S. Sulkowski M, et al. Among authors: gries jm. Clin Pharmacol Ther. 2005 Mar;77(3):214-24. doi: 10.1016/j.clpt.2004.09.008. Clin Pharmacol Ther. 2005. PMID: 15735615 Clinical Trial.

8

Chronopharmacokinetics of nicotine.

Gries JM, Benowitz N, Verotta D. Gries JM, et al. Clin Pharmacol Ther. 1996 Oct;60(4):385-95. doi: 10.1016/S0009-9236(96)90195-2. Clin Pharmacol Ther. 1996. PMID: 8873686 Clinical Trial.

9

A pooled analysis of CD4 response to zidovudine and zalcitabine treatment in patients with AIDS and AIDS-related complex.

Gries JM, Troconiz IF, Verotta D, Jacobson M, Sheiner LB. Gries JM, et al. Clin Pharmacol Ther. 1997 Jan;61(1):70-82. doi: 10.1016/S0009-9236(97)90183-1. Clin Pharmacol Ther. 1997. PMID: 9024175 Clinical Trial.

10

Pharmacokinetics of saquinavir, zidovudine, and zalcitabine in combination therapy.

Vanhove GF, Kastrissios H, Gries JM, Verotta D, Park K, Collier AC, Squires K, Sheiner LB, Blaschke TF. Vanhove GF, et al. Among authors: gries jm. Antimicrob Agents Chemother. 1997 Nov;41(11):2428-32. doi: 10.1128/AAC.41.11.2428. Antimicrob Agents Chemother. 1997. PMID: 9371345 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters